î Novartis AGã®çŸåšã®è²¡åã¹ã³ã¢ã¯8.75ã§ãã ãã®è²¡åç¶æ³ã¯å®å®ã§ãã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®å£²äžé«ã¯14.95Bã§ãåå¹Žåææ¯å¢å ã®2.88%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯å¢å ã®19.23%ãšãªããŸããã
î Novartis AGã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯8.84ã§ãã çŸåšã®PERã¯22.24ã§ãçŽè¿é«å€30.29ã36.22%äžåããçŽè¿å®å€11.26ã49.35%äžåã£ãŠããŸãã
î Novartis AGã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯6.50ã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯153.26ã§ãæé«ã¯185.00ãæäœã¯121.16ã§ãã
î Novartis AGã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯3.63ã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·162.48ãšæ¯æç·144.69ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
î Novartis AGã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯3.00ã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯7.49%ã§ãåååææ¯å¢å 5.70%ã§ãã
î Novartis AGã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯7.83ã§ãã å瀟ã®ããŒã¿å€ã¯0.47ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯äžèœå¹
ãéå®çãšãªãåŸåã瀺ããŠããŸãã